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Purpose. The purpose of the study was to examine the independent associations of adiposity and cardiorespiratory fitness with
clustered cardiometabolic risk. Methods. A cross-sectional sample of 192 adolescents (118 boys), aged 14–16 years, was recruited
from a South Lanarkshire school in the West of Scotland. Anthropometry and blood pressure were measured, and blood samples
were taken. The 20m multistage fitness test was the indicator of cardiorespiratory fitness (CRF). A clustered cardiometabolic risk
score was constructed fromHDL-C (inverted), LDL-C, HOMA, systolic blood pressure, and triglycerides. Interleukin-6, C-reactive
protein, and adiponectin were also measured and examined relative to the clustered cardiometabolic risk score, CRF, and adiposity.
Results. Although significant, partial correlations between BMI and waist circumference (WC) and both CRF and adiponectin were
negative and weak to moderate, while correlations between the BMI and WC and CRP were positive but weak to moderate. Weak
to moderate negative associations were also evident for adiponectin with CRP, IL-6, and clustered cardiometabolic risk. WC was
positively associated while CRF was negatively associated with clustered cardiometabolic risk. With the additional adjustment for
either WC or CRF, the independent associations with cardiometabolic risk persisted. Conclusion. WC and CRF are independently
associated with clustered cardiometabolic risk in Scottish adolescents.
1. Introduction
Although prediction of cardiovascular disease (CVD) risk
was previously considered pertinent to adults, it is now
accepted as a paediatric problem since the pathological
processes begin in childhood [1, 2]. Clustering of cardiometa-
bolic risk factors such as high blood pressure, insulin resis-
tance, elevated triglycerides, central obesity, low cardiorespi-
ratory fitness (CRF), physical inactivity, and lowered HDL is
routinely noted among both children and adolescents [1–3].
Of relevance to potential effects of long term exposure to the
clustering of risk factors to adulthoodmorbidity and/or mor-
tality, recent evidence indicates that a number of risk factors
associated with CVD in later life track from adolescence and
predict the extent of atherosclerotic disease in adulthood [4,
5].Measurement of risk in youth is thus potentially important
as early detection may help to identify individuals who may
be susceptible to developing CVD-related disorders.
Obesity is amajor contributor to poor risk profiles among
youth [6, 7]. Whilst obesity and overweight are associated
with increased cardiometabolic risk in adolescents [8], mod-
erate to high levels of CRF are also associatedwith a reduction
in clustering of cardiometabolic risk factors [1, 3]. Although
poor CRF and excess adiposity often occur concurrently [8],
the relative importance of each to the prediction of car-
diometabolic risk requires further study. The potential inde-
pendent effect of adiposity and CRF on cardiometabolic risk
is receiving increased attention [9, 10]. However, other more
2 BioMed Research International
recently identified risk factors for CVD may also be relevant
for the improvement of risk prediction. Adipocytokines such
as interleukin-6 (IL-6) and adiponectin as well as inflam-
matory cytokines such as C-reactive protein (CRP) are
associated with the development of atherosclerosis and type 2
diabetes in adults [11]. Since obesity is considered an inde-
pendent risk factor for CVD, it is not surprising that
both adipocytokines have been associated with poor cardio-
metabolic risk profiles in youth [12, 13]. Similar findings are
also evident for CRP [14].
Given the associations among risk factors in adults,
evidence dealing with the clustering of established and more
recently identified risk factors among youth is limited. Thus
the purpose of this study was twofold: first, to investigate
the joint associations between measures of adiposity, CRF,
IL-6, CRP, and adiponectin and clustered cardiometabolic
risk among youth and, second, to examine the independent
associations between adiposity and CRF with clustered car-
diometabolic risk. Risk factors often track from adolescence
into adulthood [5, 15], so information on their relationships is
potentially relevant to the development and implementation
of preventive measures and effective intervention strategies.
2. Methods
2.1. Sample. A cross-sectional sample of volunteers (118 boys,
74 girls, 15.0 ± 2.6 years) was recruited from South Lanark-
shire schools in the West of Scotland. Informed consent was
obtained from all students and their parents. The study was
approved by the ethics committee of the University of the
West of Scotland.All tests were undertaken between 9:00 a.m.
and noon while all measurements were taken by the same
individuals.
2.2. Physical and PhysiologicalMeasures. Barefoot staturewas
measured to the nearest 1mm (Seca Stadiometer, Seca Ltd.,
Birmingham, UK). Weight in light indoor clothing, without
shoes, was measured to the nearest 0.1 kg using calibrated
electronic weighing scales (Seca 880, Digital Scales, Seca
Ltd., Birmingham, UK). Body mass index (BMI) was cal-
culated (weight/height2, kg/m2). Waist circumference (WC),
an index of central (abdominal) adiposity, was measured at
the level midway between the lower ribs and iliac crest [16].
Sexual maturation status was self-assessed using the criteria
for pubic hair [17].
Systolic and diastolic blood pressures (SBP and DBP)
were measured with an automated monitor (Omron M10-IT
Blood Pressure Monitor HEM-7080IT-E, Omron Healthcare
UKLtd.,MiltonKeynes, UK) after each participant sat quietly
for 10min.The average of the second and third measures was
retained for analysis.
CRF was measured using the 20m multistage fitness test
(20MSFT, number of completed shuttles) which is viewed
as a valid predictor of maximal CRF in young people [18].
Specific details of the 20MSFT protocol have been described
elsewhere [19]. Participants were instructed to run until
exhaustion andwere given verbal encouragement throughout
the test.
2.3. Blood Sampling. Blood samples were taken between 9:00
and 11:00 a.m. after an overnight fast. Fasting was verified
prior to sampling. Qualified phlebotomists, experienced in
paediatric sampling techniques, obtained all blood samples.
Blood samples were obtained from an antecubital vein and
collected in a BDVacutainer plasma tube (Becton, Dickinson
and Company, Franklin Lakes, USA). Plasma was isolated
by centrifugation at 3,500 rpm for 10 minutes and frozen at
−80∘C within two hours of collection. Analyses were com-
pleted within three months of collection. Insulin, HDL-C,
LDL-C, CRP, glucose, IL-6, adiponectin, the homeostasis
model assessment (HOMA), and triglycerides (TG) were
measured with standard procedures. Triglycerides were mea-
sured by enzymaticmethods (TR210 andCH200Randox, Co.
Antrim,UK) and aCamspecM107 spectrophotometer (Cam-
spec, Leeds, UK). Concentration of HDL-C was determined
after precipitation of very-low-density and low-density
lipoproteins by the addition of phosphotungstic acid in the
presence of magnesium ions. The Friedewald formula [20]
was used to calculate LDL-C concentration. Glucose was
measured using the glucose oxidase method (GL364, Ran-
dox, Co. Antrim, UK) and analyzed with a Camspec M107
spectrophotometer (Camspec, Leeds, UK). Plasma insulin
was analyzed with commercially available immunoassay kits
(ALPCO, Salem, NH, USA) and a Camspec M107 spec-
trophotometer (Camspec, Leeds, UK). Concentrations of
IL-6 and CRP were measured with specific enzyme linked
immunosorbent assay (ELISA) kits (R & D Systems, Abing-
don, UK) and anMRXmicroplate reader (Dynatech Labora-
tories, Cambridge, MA, USA). HOMA calculation was used
as an indication of insulin resistance which was calculated as
the product of fasting glucose (mmol/L) and insulin (𝜇U/mL)
divided by the constant 22.5 [21].
2.4. Clustered Cardiometabolic Risk Score. Since differences
within individual risk markers among youth may be difficult
to identify [1], a clustered risk score for each participant
was constructed from HDL-C (inverted), LDL-C, HOMA,
SBP, and TG. These variables were selected as all are well-
established risk factors [1, 2]. A 𝑧-score (𝑧 = (value −
mean)/SD) for each variable was constructed separately for
boys and girls and by 1 yr age groups. The 𝑧-scores of the
individual risk factors were then summed to create a clustered
cardiometabolic risk score for each participant with a lower
score indicating a healthier overall risk profile.
2.5. Data Analysis. All analyses were undertaken using Sta-
tistical Package for the Social Sciences (version 18; SPSS Inc.,
Chicago, IL, USA), with values of 𝑃 < 0.05 considered
statistically significant.Datawas checked for normality of dis-
tribution before the analysis and transformed where appro-
priately. Consequently, BMI, insulin, HOMA, adiponectin,
CRF, HDL, LDL, SBP, triglycerides, and IL-6 were log-
transformed before 𝑧-scores (adjusted for sex and 1 yr age
groups) were constructed. Untransformed data are presented
throughout for ease of interpretation. Complete data for all
variables was available for 64% of the sample. Multiple impu-
tations were used to address the potential bias from missing
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data. Missing data rarely occur completely at random, and
omitting participants with one or more missing values may
lead to bias and reduction in statistical power. Consequently,
missing values were replaced through multiple imputations.
Five sets of imputations using all variables in the model were
created; the imputation was then aggregated across the 5
datasets; the pooled data were subsequently used. Multiple
imputation is recommended for epidemiological studies with
extensive missing values, as long as these amount to <60% of
the total [22]. In the present study, the extent of “missingness”
was well within this limit (<10%).
Descriptive data are presented as means and standard
deviations. Significant differences between the sexes were
determined using ANOVA, whereas differences in maturity
status between the sexes were analysed using the chi-squared
test. As no significant interaction was found for age, matura-
tion, and sex, all analyses were performed with boys and girls
together to increase statistical power. For variables where the
assumptions of normality and/or homogeneity of variance
were invalid, the nonparametric Mann-Whitney U test was
used. Partial correlations were used for bivariate associations
between adiponectin, IL-6, CRP, WC, BMI, and CRF and
clustered cardiometabolic risk. Multiple regression analysis
was used to examine the relationships between CRF,WC and
clustered cardiometabolic risk through two separate models.
Model 1 included WC or CRF and was adjusted for sex, age,
and maturity status. Model 2 included eitherWC or CRF and
was additionally adjusted for independent associations of the
two predictor variables.
3. Results
Participant characteristics are summarized in Table 1. Boys
were taller and heavier than girls (𝑃 < 0.001), while BMI was
similar between genders. Boys had a larger WC (𝑃 < 0.05)
and higher CRF (𝑃 < 0.001) than girls. Girls had higher levels
of HDL-C (𝑃 < 0.001) but lower levels of LDL-C (𝑃 < 0.05)
than boys. Partial correlations formeasures of adiposity, CRF,
metabolic markers of CVD risk, and clustered cardiometa-
bolic risk are shown in Table 2. Weak to moderate negative
associations were evident for BMI and WC with both CRF
and adiponectin and for adiponectin with CRP, IL-6, and
clustered cardiometabolic risk score. Weak to moderate
positive associations were observed between BMI and WC
and CRP.
Results of the multiple regression analyses are summa-
rized in Table 3. WC was positively associated with clustered
cardiometabolic risk (𝑃 < 0.001), while CRF was negatively
associated with clustered cardiometabolic risk (𝑃 < 0.001).
With the additional adjustment in model 2 for either WC
or CRF, the observed associations remained significant (𝑃 <
0.001).
4. Discussion
Independent relationships among two indicators of adiposity,
CRF, metabolic risk factors, and clustered cardiometabolic
risk were initially evaluated. BMI and WC were negatively
Table 1: Participant characteristics (means ± standard deviations,
except for stage of sexual maturation).
Boys (𝑛 = 118) Girls (𝑛 = 74) 𝑃 value
Age (yr) 15.14 ± 2.57 14.62 ± 2.78 0.186
Stage of pubic hair (𝑛)
I/II/III/IV/V 8/20/8/38/44 14/18/26/12/4 <0.001
Height (cm) 166.58 ± 20.96 150.85 ± 37.65 <0.001
Weight (kg) 63.22 ± 17.46 54.87 ± 15.52 <0.001
BMI (kgm−2) 22.49 ± 4.98 23.58 ± 7.78 0.455
WC (cm) 71.26 ± 9.89 67.69 ± 9.99 0.016
SBP (mmHg) 118.07 ± 23.59 117.78 ± 10.69 0.106
DBP (mmHg) 68.88 ± 15.75 68.38 ± 9.94 0.464
CRF (shuttles) 78.89 ± 25.40 41.72 ± 15.73 <0.001
HDL-C (mMol L−1) 1.66 ± 0.70 2.02 ± 0.78 <0.001
LDL-C (mMol L−1) 1.71 ± 1.51 1.14 ± 1.44 0.013
TG (mMol L−1) 0.81 ± 0.37 0.86 ± 0.39 0.395
IL-6 (pgmL−1) 4.44 ± 8.00 6.91 ± 12.54 0.304
Adiponectin (mg L−1) 9.87 ± 5.93 10.19 ± 6.96 0.222
Glucose (mMol L−1) 4.49 ± 1.03 4.37 ± 1.10 0.456
CRP (mg L−1) 1.71 ± 2.25 1.95 ± 2.19 0.479
Insulin (IUmL−1) 6.54 ± 5.60 7.94 ± 5.96 0.052
HOMA 1.33 ± 1.45 1.53 ± 1.14 0.105
BMI: body mass index; WC: waist circumference; SBP: systolic blood pres-
sure; DBP: diastolic blood pressure; CRF: cardiorespiratory fitness; HDL-
C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein
cholesterol; TG: triglycerides; IL-6: interleukin-6; CRP: C-reactive protein;
HOMA: homeostasis model assessment.
Table 2: Partial correlations (controlling for age, sex, and sexual
maturity status) between the clustered cardiometabolic risk score
(SBP + HDL-C + LDL-C + HOMA + TG), BMI, WC, CRF,
adiponectin, CRP, and IL-6.
BMI WC CRF Adiponectin CRP IL-6
BMI —
WC 0.47∗ —
CRF −0.27∗ −0.29∗ —
Adiponectin −0.28∗ −0.20∗∗ 0.08 —
CRP 0.19∗∗ 0.12 0.01 −0.21∗∗∗ —
IL-6 0.04 0.05 −0.11 −0.30∗ 0.14 —
MRS 0.04 0.01 0.02 −0.22∗∗∗ 0.28 0.13
BMI: body mass index; WC: waist circumference; CRF: cardiorespiratory
fitness; IL-6: interleukin-6; CRP: C-reactive protein; MRS: clustered car-
diometabolic risk score. ∗𝑃 < 0.001, ∗∗𝑃 < 0.05, ∗∗∗𝑃 < 0.01.
associated with both CRF and adiponectin, although only
BMI was positively associated with CRP. Adiponectin was
negatively associated with CRP, IL-6, and the clustered
cardiometabolic risk score. Although the associations were
significant, they were weak and at best moderate. This may
suggest that sufficient time may not have elapsed for the
relationships to fully develop.
Multiple regressionmodels were then used to evaluate the
independent associations ofWC and CRF with clustered car-
diometabolic risk. Both were significantly related to clustered
4 BioMed Research International
Table 3: Standardized regression coefficients examining the association of waist circumference and cardiorespiratory fitness with clustered
cardiometabolic risk.
Waist circumference Cardiorespiratory fitness
𝑅
2
𝛽 𝑅
2 change 𝑃 value 𝑅2 𝛽 𝑅2 change 𝑃 value
Model 1 0.570 0.002 0.324 <0.001 0.571 −0.073 0.326 <0.001
Model 2 0.571 0.017 0.002 <0.001 0.571 −0.078 0.000 <0.001
Model 1 is adjusted for sex, age, and sexual maturity status. Model 2 is adjusted for all covariates and either waist circumference or cardiorespiratory fitness.
cardiometabolic risk in this sample of Scottish adolescents
(Table 3).
Adiponectin was inversely related to both WC and BMI
in Scottish adolescents, consistent with other studies [13, 23].
This is not surprising since adiponectin is an atypical
adipokine with lower levels in obese and overweight individ-
uals [24]. The inverse association among adiponectin, CRP,
and IL-6 was also consistent with the literature [25, 26].
Adiponectin is known to play a protective role in the devel-
opment of insulin resistance and diabetes, both of which are
positively associated with elevated levels of CRP [27] and
IL-6 [28]. Moreover, adiponectin is an anti-inflammatory
adipokine known to indirectly decrease levels of CRP and
IL-6 through the dose-dependent, reciprocal inhibition of
tumour necrosis factor-𝛼 (TNF-𝛼) thus inhibiting these
proinflammatory cytokines [26]. Consequently, observations
in the present study may indicate that decreased produc-
tion of adiponectin contributes to the systemic and vascu-
lar inflammation commonly found in obesity through its
involvement within the regulatory pathway of several factors
including TNF-𝛼, IL-6, CRP, insulin resistance, body compo-
sition, and disease states.
Interestingly, only adiponectin was associated (nega-
tively) with the clustered cardiometabolic risk score in this
apparently healthy sample. Previous investigations in youth
have demonstrated positive associations between CRP, and
not IL-6, and clustered cardiometabolic risk [29]. A plausible
explanation for the lack of association between the cardio-
metabolic risk score and both CRP and IL-6 in the present
study may lie in the apparent health of the cohort. As IL-6 is
produced and secreted from adipose tissue, which in turn
stimulates CRP production from the liver, one would expect
elevated levels of both indicators in the presence of obesity,
increasing the likelihood of significant associations with
clustered cardiometabolic risk.Mean baseline IL-6 data in the
sample (Table 1) was nearly 4 times greater than that in the
cohort used by Andersen and colleagues (2010). The sample
of Scottish adolescents was, on average, 5 years older than
the sample described by Andersen and colleagues [29]. It is
possible that age per se and advanced sexual maturity status
contributed to the variable results. Nevertheless, the cluster-
ing of cardiometabolic risk factors may have multiple causes
independent of inflammation. Indeed, the appearance of
cardiometabolic risk may occur before high levels of inflam-
matory markers are evident.
The associations between adiponectin and clustered car-
diometabolic risk have also been previously noted in youth
[30, 31] although the present study may be the first, to the
best of our knowledge, to document similar associations in
Scottish youth. This is important given ethnic and gender
differences in adiponectin levels among cohorts [23, 32]. Fur-
ther understanding of factors associated with clustered risk
scores is important, but hypoadiponectinemia and low-grade
inflammation may act upon clustered cardiometabolic risk
differently and independently.
Results of the regression analyses (Table 3) indicated
significant associations between CRF and WC and clustered
cardiometabolic risk independently of sex, age, and sexual
maturity status.The findings were consistent with other stud-
ies showing an association between higher levels of CRF and a
healthier risk profile in children and adolescents [1, 29, 33–
35]. Previous investigations have also demonstrated a nega-
tive relationship between CRF andmeasures of adiposity [36]
and a stronger relationship between measures of adiposity
and CVD risk than that between CRF and clustered risk [37,
38]. Although CRFwas associated withmeasures of adiposity
in this sample (Table 2), results of the multiple regression
analyses (Table 3) indicated that neither CRF nor WC was
more strongly associated with clustered cardiometabolic risk.
Significant associations between WC (positive) and CRF
(negative) and clustered cardiometabolic risk were noted,
but the strength of the associations was enhanced, albeit
marginally, after controlling for either CRF or WC in the
second regressionmodel.Thefinding thatWCwas independ-
ently associated with clustered cardiometabolic risk, after
controlling for CRF, was consistent with some [3, 37] but not
all [36, 39] studies of youth. Potential explanations for the
variable results may relate to sampling variation, measure-
ment protocols, and indicators of risk used in the different
studies. Although the observations of this study are limited
due to its cross-sectional nature, the strength of the present
study is the measurement of traditional CVD risk factors in
addition to adiponectin, IL-6, and CRP in a young cohort
with findings indicating that measures of fatness may have
different associations with markers of inflammation and that
both WC and CRF act independently upon components of
the cardiometabolic risk score.
5. Conclusion
Few studies have examined the relationships between
adiponectin, inflammatory cytokines, and clustered cardio-
metabolic risk in adolescents. The findings indicated an
association between adiponectin and clustering of CVD risk
factors. Given the pleiotropic effects of adiponectin, further
research is needed to establish the utility of adiponectin as an
independent indicator of cardiometabolic risk within diverse
youth populations. The relative importance of adiposity and
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CRF in the management of cardiometabolic risk was also
noted in this sample of Scottish youth.
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